LeonaBio, Inc.
Biotechnology company · Bothell, Washington, United States · Nasdaq: LONA
LeonaBio, Inc. is a biotechnology company headquartered in Bothell, Washington, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker LONA. It has reported private securities offerings to the US SEC, most recently $89 million sold in a notice filed in 2020.
LeonaBio at a glance
What does LeonaBio do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $89 million sold (2020).
Frequently asked questions about LeonaBio
Where is LeonaBio headquartered?
LeonaBio, Inc. is headquartered in Bothell, Washington, United States.
What does LeonaBio do?
LeonaBio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is LeonaBio a public company?
Yes. LeonaBio, Inc. trades on Nasdaq under the ticker LONA.
When was LeonaBio founded?
The earliest incorporation on record for LeonaBio, Inc. is in 2011, according to public company registers.
Similar companies
- PharmaIN CorpBothell, Washington, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.